Home › Bayer: FDA will speed review of 2 respiratory...
 

Keywords :   


Bayer: FDA will speed review of 2 respiratory...

2014-11-25 04:15:44| Chemicals - Topix.net

Two medicines Bayer HealthCare Pharmaceuticals Inc. is testing for respiratory disorders will get priority review by U.S. regulators and other benefits under a 2012 program to boost development of new antibiotics. Bayer HealthCare, based in Whippany, New Jersey, said Monday the Food and Drug Administration has designated two of its experimental treatments as qualified infectious disease products.

Tags: review speed respiratory bayer

Category:Chemicals

Latest from this category

All news
23.11Weekly Recap: PPG, John Morikis, Sika Top This Weeks Stories
22.11Andrea Wagner Watts to Deliver Keynote Address at ACAs 2025 CoatingsTech Conference
22.11Hempels Infinity Silicone Hull Paint Recharger Launched for Yachts
22.11The Lehigh 56th Annual Short Course Website is Open
21.11allnex Announces Strategic Investment in East St. Louis Site
21.11Syensqo Expands Polymer Production Capacity
21.11¦nie¿ka Publishes Results for Three Quarters of 2024
21.11Sheboygan Paint Company Names New Customer Service Manager
Chemicals »
25.11New2DS LL ×AC
25.11Playstation vita Wi-Fi
25.11 UGC
25.11
25.11Soomloom
25.11BMW Z4 M coupe 2009 PMA
25.11 DVD-BOX
25.11(mizuki) ()
More »